The Gastric Cancer Foundation has announced the launch of its 2022 grant program. The Foundation plans to award a total of $200,000 in new grant funding and is now accepting letters of intent from researchers who are working on novel projects aimed at discovering new therapies for this challenging disease. Grant recipients will be awarded one-time grants up to $100,000.
The Gastric Cancer Foundation has prioritized early-stage seed funding, as it enables researchers to generate preliminary data to submit compelling and competitive applications for larger research grants. This type of early funding is often difficult to obtain.
The objective of GCF’s grant program is to support research projects that will facilitate the clinical development of new therapies or regimens for the treatment of gastric cancer. Grant applications will be reviewed and rated by scientific advisors, and funding decisions will be made by the GCF Board of Directors no later than September 30, 2022.
Researchers who are interested in applying for a grant should email a letter of intent to GCF by April 29 to grants@gastriccancer.org. Researchers who are selected to submit full applications will be notified shortly thereafter and invited to submit their applications no later than July 15. More information can be found at gastriccancer.org.
‌
‌
‌
‌
‌
‌
‌